OKYO Pharma CEO Announces First Dosing in Phase 2 Trial for OK-101 to Treat Neuropathic Corneal Pain

By Proactive Investors / October 24, 2024 / www.youtube.com / Article Link


OKYO Pharma CEO Gary Jacob joined Steve Darling from Proactive to share news the company is reporting the first patient has ...

Recent News

Copper price estimates boosted by AOCE

October 05, 2026 / www.canadianminingreport.com

AOCE makes significant changes to metal estimates

October 05, 2026 / www.canadianminingreport.com

Big Gold still struggling overall in 2026

September 28, 2026 / www.canadianminingreport.com

Gold stocks down on metal price pullback

September 28, 2026 / www.canadianminingreport.com

Mining sector far outpaces tech over past three years

September 21, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok